Cover Image
市場調查報告書

癌症治療的新藥物遞輸系統(NDDS)市場分析與預測:各產品(奈米粒子,粒子狀栓塞物質),地區 2014年∼2025年

Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 600793
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
癌症治療的新藥物遞輸系統(NDDS)市場分析與預測:各產品(奈米粒子,粒子狀栓塞物質),地區 2014年∼2025年 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Analysis By Product (Nanoparticles and Embolization Particles), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2014 - 2025
出版日期: 2017年12月18日 內容資訊: 英文 92 Pages
簡介

癌症治療的新藥物遞輸系統(NDDS)市場,預計2025年達到266億1000萬美元。這個市場主要,由於癌症發病率的全世界的上升,NDDS技術開發的研究活動的增加,進行中的計劃的研究資金被推進。

本報告提供癌症治療的新藥物遞輸系統(NDDS)市場相關調查,市場概要,各產品、地區的市場趨勢,市場規模的變化與預測,成長影響要素分析,市場佔有率,競爭情形,主要企業的簡介等,全面的資訊。

目錄

第1章 調查方法

  • 資訊採購
  • 資料分析

第2章 摘要整理

  • 市場概要

第3章 癌症治療的新藥物遞輸系統(NDDS)市場

  • 市場區隔和範圍
  • 市場成長要素分析
  • 市場阻礙因素分析
  • 滲透與成長預測製圖
  • SWOT分析
  • 產業分析 - 波特的五力分析

第4章 癌症治療的新藥物遞輸系統(NDDS)市場:各產品

  • 市場趨勢分析:各產品
  • 奈米粒子
    • 微脂體
    • Micelle
    • 聚合物
    • 其他
  • 栓塞粒子
    • 聚乙烯醇(PVA)粒子
    • 釋藥微球
    • 液體栓塞物質
    • 其他

第5章 癌症治療的新藥物遞輸系統(NDDS)市場:各地區

  • 市場趨勢分析:各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第6章 競爭情形

  • 參與企業的一覽
  • 企業簡介
目錄
Product Code: GVR-2-68038-267-9

The global novel drug delivery systems (NDDS) in cancer therapy market is expected to reach USD 26.61 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by global rise in incidence of cancer, increase in research activities for developing novel drug delivery technologies, and availability of research funding for ongoing projects.

Many key players in this market are investing in R&D of novel and advanced products. This can also be attributed to increase in patent expirations. For instance, the R&D expenditure of Celgene Corporation increased from USD 3,697.3 million in 2015 to USD 4,470.1 million in 2016. Increase in R&D spending was directed toward enhancing product pipeline and for regulatory approvals of new products.

In addition, rise in healthcare expenditure for diagnosis and treatment of cancer and awareness about alternative therapies are expected to boost market growth. Improvement in healthcare infrastructure in developing nations and increase in awareness about new treatment methods for cancer are also anticipated to propel the market during the forecast period.

North America held the largest market share in 2016. Local presence of a large number of manufacturers, ongoing regulatory approvals for new drugs, and availability of research funding for new methods of treatment for this disorder are key factors that can be attributed to this region's dominance in the global market. However, Asia Pacific is expected to grow at the highest rate during the forecast period. This can be attributed to rise in initiatives that boost cancer research projects, increase in healthcare expenditure for cancer therapy, improvement in healthcare infrastructure, large geriatric population base, and rise in awareness owing to medical conferences and meetings in the region.

Further Key Findings From the Report Suggest:

  • The nanoparticles segment held the largest revenue share in 2016 due to increase in funding for research using these particles
  • The embolization particles segment is expected to grow at the highest rate during the forecast period owing to higher precision rate and accurate drug delivery
  • North America dominated the global market due to presence of a large number of cancer patients and favorable reimbursement scenario
  • Some of the key players are Celgene Corporation; Teva Pharmaceutical Industries, Ltd.; GALEN; Shire; Johnson & Johnson Services, Inc.; and Spectrum Pharmaceuticals, Inc.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing research on new therapies for cancer backed by research funding
    • 3.2.2 Rise in number of cancer cases globally
      • 3.2.2.1 Estimated New Cancer Cases, by type, U.S. in 2016
  • 3.3 Market Restraint Analysis
    • 3.3.1 Lack of awareness and funding for novel drug delivery systems in emerging nations
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Novel Drug Delivery Devices (NDDS) in Cancer Therapy Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.6 Industry Analysis - Porter's

Chapter 4 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product Estimates & Trend Analysis

  • 4.1 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product Movement Analysis
  • 4.2 Nanoparticles
    • 4.2.1 Nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.2 Liposomes
      • 4.2.2.1 Liposomes market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.3 Micelles
      • 4.2.3.1 Micelles market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.4 Polymers
      • 4.2.4.1 Polymers market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.2.5 Other nanoparticles
      • 4.2.5.1 Other nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3 Embolization Particles
    • 4.3.1 Embolization particles market estimates and forecasts, 2014 - 2025 (USD Million),
    • 4.3.2 PVA particles
      • 4.3.2.1 PVA particles market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.3 Drug eluting beads
      • 4.3.3.1 Drug eluting beads market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.4 Liquid emboli
      • 4.3.4.1 Liquid emboli market estimates and forecasts, 2014 - 2025 (USD Million)
    • 4.3.5 Other embolization particles
      • 4.3.5.1 Other embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional Estimates & Trend Analysis, By Product

  • 5.1 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional Movement Analysis
  • 5.2 North America
    • 5.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.2.2 U.S.
      • 5.2.2.1 Market estimates & forecasts, by product 2014 - 2025 (USD Million)
    • 5.2.3 Canada
      • 5.2.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • 5.3 Europe
    • 5.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.3.2 U.K.
      • 5.3.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.3.3 Germany
      • 5.3.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • 5.4 Asia Pacific
    • 5.4.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.4.2 Japan
      • 5.4.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.4.3 China
      • 5.4.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • 5.5 Latin America
    • 5.5.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.5.2 Brazil
      • 5.5.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.5.3 Mexico
      • 5.5.3.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • 5.6 Middle East and Africa (MEA)
    • 5.6.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)
    • 5.6.2 South Africa
      • 5.6.2.1 Market estimates & forecasts, by product, 2014 - 2025 (USD Million)

Chapter 6 Competitive Landscape

  • 6.1 List of Market Players
  • 6.2 Company Profiles
    • 6.2.1 Teva Pharmaceutical Industries Ltd.
      • 6.2.1.1 Company overview
      • 6.2.1.2 Financial performance
      • 6.2.1.3 Product benchmarking
    • 6.2.2 Johnson & Johnson Services, Inc.
      • 6.2.2.1 Company overview
      • 6.2.2.2 Financial performance
      • 6.2.2.3 Product benchmarking
    • 6.2.3 GALEN
      • 6.2.3.1 Company overview
      • 6.2.3.2 Financial performance
      • 6.2.3.3 Product benchmarking
      • 6.2.3.4 Strategic initiatives
    • 6.2.4 Merrimack Pharmaceuticals, Inc.
      • 6.2.4.1 Company overview
      • 6.2.4.2 Financial performance
      • 6.2.4.3 Product benchmarking
      • 6.2.4.4 Strategic initiatives
    • 6.2.5 Shire (Baxalta)
      • 6.2.5.1 Company overview
      • 6.2.5.2 Financial performance
      • 6.2.5.3 Product benchmarking
    • 6.2.6 Samyang Biopharmaceuticals Corporation
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial performance
      • 6.2.6.3 Product benchmarking
      • 6.2.6.4 Strategic initiatives
    • 6.2.7 Celgene Corporation
      • 6.2.7.1 Company overview
      • 6.2.7.2 Financial performance
      • 6.2.7.3 Product benchmarking
      • 6.2.7.4 Strategic initiatives
    • 6.2.8 Spectrum Pharmaceuticals, Inc.
      • 6.2.8.1 Company overview
      • 6.2.8.2 Financial performance
      • 6.2.8.3 Product benchmarking
      • 6.2.8.4 Strategic initiatives

List of Tables

  • TABLE 1 North America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 2 North America nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 3 North America embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 4 U.S. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 5 U.S. nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 6 U.S. embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 7 Canada Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 8 Canada nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 9 Canada embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 10 Top 10 countries with highest cancer rates,2012
  • TABLE 11 Europe novel drug delivery systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 12 Europe nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 13 Europe embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 14 U.K. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 15 U.K. nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 16 U.K. embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 17 Germany Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 18 Germany nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 19 Germany embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 20 Asia Pacific Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 21 Asia Pacific nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 22 Asia Pacific embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 23 Japan Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 24 Japan nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 25 Japan embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 26 China Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 27 China nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 28 China embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 29 Latin America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 30 Latin America nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 31 Latin America embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 32 Brazil Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 33 Brazil nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 34 Brazil embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 35 Mexico Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 36 Mexico nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 37 Mexico embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 38 MEA Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 39 MEA nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 40 MEA embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 41 South Africa Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, by product, 2014 - 2025 (USD Million)
  • TABLE 42 South Africa nanoparticles market estimates & forecasts, by type, 2014 - 2025 (USD Million)
  • TABLE 43 South Africa embolization particles market estimates & forecasts, by type, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market snapshot (USD Million), 2016
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT Analysis, by factor (Political & legal, economic, and technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product outlook and key takeaways (USD Million)
  • FIG. 16 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Product movement analysis (USD Million)
  • FIG. 17 Nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 18 Liposomes market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 19 Micelles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 20 Polymers market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 21 Other nanoparticles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 22 Embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 23 PVA particles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 24 Drug eluting beads market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 25 Liquid emboli market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 26 Other embolization particles market estimates and forecasts, 2014 - 2025 (USD Million)
  • FIG. 27 Regional market place: Key takeaways (USD Million)
  • FIG. 28 Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market: Regional movement analysis (USD Million)
  • FIG. 29 North America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 30 The U.S. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 31 Canada Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 32 Europe Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 33 U.K. Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 34 Germany Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 35 Asia Pacific Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 36 Japan Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 37 China Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 38 Latin America Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 39 Brazil Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 40 Mexico Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 41 MEA Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
  • FIG. 42 South Africa Novel Drug Delivery Systems (NDDS) in cancer therapy market estimates & forecasts, 2014 - 2025 (USD Million)
Back to Top